HUE047242T2 - Eljárás magzati alkohol spektrumzavar diagnosztizálására - Google Patents

Eljárás magzati alkohol spektrumzavar diagnosztizálására

Info

Publication number
HUE047242T2
HUE047242T2 HUE16736402A HUE16736402A HUE047242T2 HU E047242 T2 HUE047242 T2 HU E047242T2 HU E16736402 A HUE16736402 A HU E16736402A HU E16736402 A HUE16736402 A HU E16736402A HU E047242 T2 HUE047242 T2 HU E047242T2
Authority
HU
Hungary
Prior art keywords
acolhol
fetal
diagnosis
spectrum disorder
disorder
Prior art date
Application number
HUE16736402A
Other languages
English (en)
Inventor
Bruno Jose Gonzalez
Stephane Marret
Matthieu Jean Alexandre Lecuyer
Annie Laquerriere
Soumeya Bekri
Celine Lesueur
Sylvie Marguerite Alberte Jegou
Pascale Yvonne Josephine Marcorelles
Original Assignee
Univ Rouen Centre Hospitalier
Univ Rouen Normandie
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rouen Centre Hospitalier, Univ Rouen Normandie, Inst Nat Sante Rech Med filed Critical Univ Rouen Centre Hospitalier
Publication of HUE047242T2 publication Critical patent/HUE047242T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/515Angiogenesic factors; Angiogenin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
HUE16736402A 2015-06-22 2016-06-22 Eljárás magzati alkohol spektrumzavar diagnosztizálására HUE047242T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1555727A FR3037657B1 (fr) 2015-06-22 2015-06-22 Methode de diagnostic des troubles causes par l'alcoolisation foetale

Publications (1)

Publication Number Publication Date
HUE047242T2 true HUE047242T2 (hu) 2020-04-28

Family

ID=54329676

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16736402A HUE047242T2 (hu) 2015-06-22 2016-06-22 Eljárás magzati alkohol spektrumzavar diagnosztizálására

Country Status (17)

Country Link
US (1) US10793908B2 (hu)
EP (1) EP3311174B1 (hu)
JP (1) JP6663936B2 (hu)
KR (1) KR20180063036A (hu)
CN (1) CN108450002A (hu)
AU (1) AU2016282842A1 (hu)
BR (1) BR112017027707A2 (hu)
CA (1) CA2990304A1 (hu)
DK (1) DK3311174T3 (hu)
ES (1) ES2758424T3 (hu)
FR (1) FR3037657B1 (hu)
HK (1) HK1253894B (hu)
HR (1) HRP20192085T1 (hu)
HU (1) HUE047242T2 (hu)
PL (1) PL3311174T3 (hu)
PT (1) PT3311174T (hu)
WO (1) WO2016207253A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10585028B2 (en) 2017-10-20 2020-03-10 Charted Scientific, Inc. Method and apparatus for optical analysis
US11041756B2 (en) 2017-10-20 2021-06-22 Charted Scientific Inc. Method and apparatus of filtering light using a spectrometer enhanced with additional spectral filters with optical analysis of fluorescence and scattered light from particles suspended in a liquid medium using confocal and non confocal illumination and imaging
WO2019199871A1 (en) 2018-04-10 2019-10-17 Quanterix Corporation Quantification of neurofilament light chain in physiological samples
FR3081707A1 (fr) * 2018-05-30 2019-12-06 Universite De Rouen Normandie Traitement des troubles neurologiques causes par l'alcoolisation foetale
US11883186B2 (en) 2019-03-06 2024-01-30 San Diego State University (Sdsu) Foundation Methods and systems for continuous measurement of anomalies for dysmorphology analysis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0312818B8 (pt) * 2002-07-19 2021-05-25 Beth Israel Deaconess Medical Ct Inc uso de uma medida do nível do polipeptídeo sflt-1 em uma amostra de uma paciente e uso de uma medida dos níveis de pelo menos dois dos peptídeos sflt1, vegf livre ou polipeptídio pigf livre em uma amostra de um paciente usando um métrico
US20060037085A1 (en) * 2004-08-13 2006-02-16 Ying Peng Animal model for fetal alcohol syndrome and methods of treatment
CN104391125B (zh) * 2006-12-08 2017-10-03 李尹雄 通过干细胞营养物进行的器官的形成和复壮以及酒精损伤的器官的再生
US8383352B2 (en) * 2009-06-05 2013-02-26 Northwestern University Detection of maternal alcohol exposure
CN102895219A (zh) * 2012-10-26 2013-01-30 中山大学孙逸仙纪念医院 虾青素在胎儿酒精相关性疾病中的应用

Also Published As

Publication number Publication date
FR3037657A1 (fr) 2016-12-23
DK3311174T3 (da) 2019-11-18
JP6663936B2 (ja) 2020-03-13
CN108450002A (zh) 2018-08-24
HK1253894B (zh) 2020-07-10
US10793908B2 (en) 2020-10-06
EP3311174B1 (fr) 2019-08-28
HRP20192085T1 (hr) 2020-02-21
CA2990304A1 (fr) 2016-12-29
WO2016207253A1 (fr) 2016-12-29
ES2758424T3 (es) 2020-05-05
EP3311174A1 (fr) 2018-04-25
PT3311174T (pt) 2019-11-22
BR112017027707A2 (pt) 2018-09-11
PL3311174T3 (pl) 2020-03-31
KR20180063036A (ko) 2018-06-11
FR3037657B1 (fr) 2017-06-23
US20180195124A1 (en) 2018-07-12
JP2018519819A (ja) 2018-07-26
AU2016282842A1 (en) 2018-01-25

Similar Documents

Publication Publication Date Title
IL286853B (en) Methods for diagnosing sepsis
IL251560A0 (en) Methods for preparing ribosides
EP3288455C0 (en) DIAGNOSTIC METHODS
HK1251022A1 (zh) 診斷方法
HK1252996A1 (zh) 用於治療癲癇的方法
IL251747A0 (en) A method for analyzing the brain activity of a subject
HK1253894B (zh) 診斷胎兒酒精光譜紊亂的方法
PL3197506T3 (pl) Sposób suszenia kanałów endoskopu
IL248283B (en) A method for the synthesis of cloprabine
GB201508860D0 (en) Diagnostic method
GB201409851D0 (en) Diagnostic method
GB201615753D0 (en) Diagnostic method
GB201504297D0 (en) Diagnosis
GB201408875D0 (en) Diagnostic method
GB201418803D0 (en) Diagnostic Apparatus
EP3535421C0 (en) DIAGNOSTIC METHODS
GB201509658D0 (en) Method of diagnosis
GB201621945D0 (en) Method of diagnosis
GB201615330D0 (en) Method of diagnosis
PT3320102T (pt) Processo para a síntese de pentostatina
GB201521972D0 (en) Companion diagnostic
GB201516557D0 (en) Diagnosis
GB201515556D0 (en) Nanoparticle synthesis method
GB201512391D0 (en) Diagnostic platform
GB201509128D0 (en) Novel healthcare diagnostic method